Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. User Boards ›
  4. NASDAQ OMX GlobeNewswire Message Board

Oxford Technology VCT plc : Half-year Report Ox

Message Board Public Reply | Private Reply | Keep | Replies (0)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 301275
(Total Views: 24)
Posted On: 10/23/2017 3:00:21 AM
Avatar
Posted By: News Desk 2018
Oxford Technology VCT plc : Half-year Report

Oxford Technology Venture Capital Trust Plc

Unaudited Half-Yearly Report

For the period

1 March 2017 to 31 August 2017

Financial Headlines

  6 Months Ended 31 August 2017 Year Ended 28 February 2017  
Net Assets at Period End   £2.85m £2.89m
Net Asset Value per Share   52.6p 53.2p
Cumulative Dividend per Share   55.0p 54.0p
Total NAV Return per Share   107.6p 107.2p
Share Price at Period End   35.0p 35.0p
Earnings per Share 0.4p (6.7)p  

Company Number: 3276063 Registered Address: The Magdalen Centre, Oxford Science Park, Oxford OX4 4GA

Statement on behalf of the Board

I am pleased to present the unaudited results for the six month period ended 31 August 2017.

Results and Dividends The Company's net asset value (NAV) per share has decreased by 0.6p from 53.2p at 28 February 2017 to 52.6p at 31 August 2017.  The underlying NAV per share rose by 0.4p but was offset by the payment of a 1p per share dividend on 21 July 2017.

Portfolio Review The companies within the portfolio continue to develop.

Select Technology, a photocopier (or more generally Multi Function Device, or MFD) software company, remains the largest holding in your Company's portfolio.  The company is profitable and continues to grow, despite the continued execution of a planned transition to reduce dependency on one particular supplier, which will have the effect of increasing business resilience.  Taking these developments into account, we have reverted to a valuation methodology based on a sales multiple to more appropriately reflect the prospects of the business, although the impact of this is small during the half year period. 

Scancell has a strong novel cancer related clinical development pipeline. SCIB1, targeting malignant melanoma, has had good Phase1/2 results and a Phase 2 combination trial with an immune checkpoint inhibitor is planned for 2018.  SCIB2 targets non-small lung cancer and Modi-1 targets breast and ovarian cancers and osteosarcoma. Four Phase 1/2 trials on each target are also planned for 2018.  Scancell raised £5 million at 10p per share during the reporting period in an oversubscribed AIM placing - your company did not take part in this due to restrictive VCT rules.  The net proceeds of the placing (£4.7 million after expenses) are being used to support the Company's clinical development pipeline of novel cancer immunotherapies and to continue to support the pipeline arising from the ImmunoBody platform.

The bid price of Scancell's shares used for the calculation of the Company's net asset value on 31 August 2017 was 14.0p, unchanged from the bid price on 28 February 2017.

The Directors along with the Investment Advisor continue to take an active interest in the remaining companies within the portfolio, both to support their management teams to achieve company development, but also to prepare companies for realisation at the appropriate time.  It should be noted that the current portfolio is highly concentrated with Select representing 51% and Scancell 35% of the VCT's equity - your Company's NAV is therefore very sensitive to changes in the valuations of these two portfolio companies.

Liquidity At period end we had net current assets of £123k.

VCT qualifying status The Board has procedures in place to ensure that the Company continues to comply with the conditions laid down by HMRC for maintaining approval as a VCT.

Presentation of half-yearly report In order to reduce the length of this report, we have omitted details of the Company's objectives and investment strategy, its Advisers and Registrar and how to buy and sell shares in the Company. These details are all included in the Annual Reports, which together with previous half-yearly reports, are available for viewing on the Oxford Technology website.

Outlook Your directors continue to monitor changes to VCT legislation, and its potential impact on both the VCT and its investee companies. The recent publication of the Patient Capital Review makes many recommendations regarding investment into early stage high growth companies. It is expected that this may drive additional changes to tax efficient investment schemes. Your directors do not expect that this will have any material impact on the current portfolios or on current investors as the VCT is fully invested. Likewise, whilst the impact of Brexit remains unclear, your directors do not expect its eventual outcome to have a material impact on portfolio valuations.

The directors' view remains that the portfolio, while concentrated, still holds significant potential over the medium term but is not without risk.  In our previous quarterly update, the Board announced that it wishes to have in place appropriate plans to ensure any further realisations do not result in your VCT becoming sub-economic, and to this end the Board is continuing to consider all the options open to your VCT.  Should the Board consider any such proposal to be in the best interests of existing shareholders, a further announcement will be made.  However, there can be no certainty that any of these discussions will lead to a concrete proposal, at this time or in the future.

Finally, I would like to take this opportunity to thank shareholders, many whom we were able to welcome to our AGM in July, for their continued support.

Alex Starling Chairman 20 October 2017

Investment Portfolio as at 31 August 2017

Company Description Net Cost of investment £'000 Carrying value at 31/8/17 £'000 Change in value for the 6 month period £'000 % Equity held OT1 % Equity held All OT % of fund investment value
Select Technology   Photocopier interfaces 488 1,400 21 30.0 58.6 51.3
Scancell (bid price 14p) Antibody based cancer therapeutics 344 964 - 2.2 3.8 35.3
Getmapping   Aerial photography 518 249 21 3.9 3.9 9.1
Biocote Bactericidal powder coating 85 119 13 6.6 6.6 4.3
Total Investments     1,435 2,732 55     100%
  Other Net Assets       123          
  Net Assets       2,855          

Responsibility Statement of the Directors in respect of the half-yearly report

We confirm that to the best of our knowledge:

  • the half-yearly financial statements have been prepared in accordance with the statement "Interim Financial Reporting" issued by the Financial Reporting Council;
  • the half-yearly report includes a fair review of the information required by the Financial Services Authority Disclosure and Transparency Rules, being:
  • an indication of the important events that have occurred during the first six months of the financial year and their impact on the condensed set of financial statements.
  • a description of the principal risks and uncertainties for the remaining six months of the year.
  • a description of related party transactions that have taken place in the first six months of the current financial year that may have materially affected the financial position or performance of the Company during that period and any changes in the related party transactions described in the last annual report that could do so.

On behalf of the Board: Alex Starling - Chairman 20 October 2017

Income Statement

  Six months to 31 Aug 2017 Six months to 31 Aug 2016 Year to 28 February 2017
  Revenue Capital Total Revenue Capital Total Revenue Capital Total
  £'000 £'000 £'000 £'000 £'000 £'000 £'000 £'000 £'000
                   
Gain/(Loss) on disposal of fixed asset investments - - - - - - - - -
Unrealised gain/(loss) on valuation of fixed asset investments - 55 55 - 30 30 - (393) (393)
Investment income 7 - 7 - - - 110 - 110
Investment management fees (4) (11) (15) (4) (13) (17) (8) (25) (33)
Other expenses (27) - (27) (24) - (24) (51) - (51)
                   
Return on ordinary activities before tax (24) 44 20 (28) 17 (11) 51 (418) (367)
                   
Taxation on ordinary activities - - - - - - - - -
                   
                   
Return on ordinary activities after tax (24) 44 20 (28) 17 (11) 51 (418) (367)
                   
Earnings per share - basic and diluted (0.4)p 0.8p 0.4p (0.5)p 0.3p (0.2)p 1.0p (7.7)p (6.7p)
  • The 'Total' column of this statement is the profit and loss account of the Company; the supplementary Revenue return and Capital return columns have been prepared under guidance published by the Association of Investment Companies.
  • All revenue and capital items in the above statement derive from continuing operations.
  • The accompanying notes are an integral part of the half-yearly report.
  • The Company has only one class of business and derives its income from investments made in shares and securities and from bank and money market funds.

The Company has no recognised gains or losses other than the results for the period as set out above. Accordingly a Statement of Comprehensive Income is not required. Balance Sheet

  As at 31 Aug 2017 As at 31 Aug 2016 As at 28 February 2017
  £'000 £'000 £'000 £'000 £'000 £'000
             
Fixed asset investments*     2,732   3,102   2,678
Current assets:            
Debtors 14   18   2  
  Creditors : Amounts falling due within one year (9)   (6)   (8)  
  Cash at Bank 118   131   217  
  Net current assets   123   143   211
             
Net assets   2,855   3,245   2,889
             
Called up equity share capital   543   543   543
             
Share premium   176   176   176
             
Unrealised capital reserve   1,297   1,666   1,242
             
Profit and Loss account reserve   839   860   928
             
Total equity shareholders' funds   2,855   3,245   2,889
  Net asset value per share   52.6p   59.7p   53.2p

* At fair value through profit and loss

Statement of Changes in Equity

  Share Capital £'000 Share Premium £'000 Unrealised Capital Reserve £'000 Profit & Loss   Reserve £'000 Total  £'000
           
As at 1 March 2016 543 176 1,346 1,262 3,327
Revenue return on ordinary activities after tax - - - (28) (28)
Expenses charged to capital - - - (13) (13)
Current period gains on fair value of investments - - 30 - 30
Prior years' unrealised losses now realised - - 290 (290) -
Dividends paid - - - (71) (71)
Balance as at 31 August 2016 543 176 1,666 860 3,245
As at 1 March 2016 543 176 1,346 1,262 3,327
Revenue return on ordinary activities after tax - - - 51 51
Expenses charged to capital - - - (25) (25)
Current period losses on fair value of investments - - (393) - (393)
Prior years' unrealised losses now realised - - 289 (289) -
Dividends paid - - - (71) (71)
Balance as at 28 February 2017 543 176 1,242 928 2,889
As at 1 March 2017 543 176 1,242 928 2,889
Revenue return on ordinary activities after tax - - - (24) (24)
Expenses charged to capital - - - (11) (11)
Current period gains on fair value of investments - - 55 - 55
Dividends paid - - - (54) (54)
Balance as at 31 August 2017 543 176 1,297 839 2,855

Statement of Cash Flows

  Six months to 31 Aug 2017 Six months to 31 Aug 2016 Year to 28 February 2017
  £'000 £'000 £'000
Cash flows from operating activities      
Return on ordinary activities before tax 20 (11) (367)
Adjustments for:      
Increase in debtors (12) (15) -
Increase/(decrease) in creditors 2 (4) (1)
Gain on disposal of fixed asset investments investm - - -
(Gain)/loss on valuation of fixed asset investments (55) (30) 393
(Outflow)/inflow from operating activities (45) (60) 25
Cash flows from investing activities      
Purchase of fixed asset investments - - -
Sale of fixed asset investments - 9 10
Total cash flows from investing activities - 9 10
       
Cash flows from financing activities      
       
Dividends paid (54) (71) (71)
Total cash flows from financing activities (54) (71) (71)
       
Increase/(decrease) in cash and cash equivalents (99) (122) (36)
       
Opening cash and cash equivalents 217 253 253
       
Closing cash and cash equivalents 118 131 217

   Notes to the Half-Yearly Report

1.         Basis of preparation The unaudited half-yearly results which cover the six months to 31 August 2017 have been prepared in accordance with the Financial Reporting Council's (FRC) Financial Reporting Standard 104 Interim Financial Reporting ('FRS 104') and the Statement of Recommended Practice (SORP) for Investment Companies re-issued by the Association of Investment Companies in November 2014. Details of the accounting policies and valuation methodologies are included in the Annual Report.

2.         Publication of non-statutory accounts The unaudited half-yearly results for the six months ended 31 August 2017 do not constitute statutory accounts within the meaning of Section 415 of the Companies Act 2006. The comparative figures for the year ended 28 February 2017 have been extracted from the audited financial statements for that year, which have been delivered to the Registrar of Companies. The independent auditor's report on those financial statements, in accordance with chapter 3, part 16 of the Companies Act 2006, was unqualified. This half-yearly report has not been reviewed by the Company's auditor.

3.         Earnings per share The calculation of earnings per share for the period is based on the return attributable to shareholders divided by the weighted average number of shares in issue during the period. There are no potentially dilutive capital instruments in issue and, therefore, no diluted returns per share figures are relevant.

4.         Net asset value per share The net asset value per share is based on the net assets at the period end divided by the number of shares in issue at that date (5,431,655 in each case).

5.         Principal risks and uncertainties The Company's assets consist of equity and fixed interest investments, cash and liquid resources. Its principal risks are therefore market risk, credit risk and liquidity risk. Other risks faced by the Company include economic, loss of approval as a Venture Capital Trust, investment and strategic, regulatory, reputational, operational and financial risks. These risks, and the way in which they are managed, are described in more detail in the Company's Annual Report and Accounts for the year ended 28 February 2017. The Company's principal risks and uncertainties have not changed materially since the date of that report.

6.         Related party transactions OT1 Managers Ltd, a wholly owned subsidiary, provides investment management services to the Company for a fee of 1% of net assets per annum.

7.          Copies of this statement are available from Oxford Technology Management, The Magdalen Centre, Oxford Science Park, Oxford OX4 4GA and on the Company's website - www.oxfordtechnology.com /vct1.

Board Directors : Alex Starling, Robin Goodfellow, Richard Roth and David Livesley

Investment Manager : OT1 Managers Ltd with services contracted to Oxford Technology Management Ltd

Website: www.oxfordtechnology.com/vct1

Enquiries: Lucius Cary, Oxford Technology Management 01865 784466



(0)
(0)








Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us